FEI Tribunal issues Consent Awards in equine anti-doping case
19 April 2022
Author: FEI
The FEI Tribunal has issued Consent Awards in an equine anti-doping case involving a Banned Substance.
In this case, the horse Basc Trio (FEI ID 106QW17/UAE), tested positive for the Banned Substance 5α-estrone-3β, 17α-diol (metabolite of Nandrolone), following samples taken at the CEI1*100 Dubai (UAE), 7-14 November 2021.
The athlete, Abdul Aziz Salah Abdulla Ameen (FEI ID 10063337/UAE) and the trainer, Amr Mohd Atris El Sayed (FEI ID 10054579/UAE), admitted the rule violation and accepted the consequences. In its final decisions, the FEI Tribunal disqualified the horse and athlete combination from the event and imposed an 18-month ineligibility period on the athlete and on the trainer; the provisional suspension each has already served shall be credited against the imposed ineligibility period. The athlete and trainer were also each fined CHF 5,000.
The Consent Awards are available here.
Separately, the FEI has announced a new adverse analytical finding (AAF) involving an equine prohibited substance. The case involves *Banned Substance under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs).
In the following Endurance case, the athlete and the trainer have been provisionally suspended until the FEI Tribunal renders its decisions. The horse has been provisionally suspended for two months from the date of notification.
Case 2022/BS04:
Horse: Dactyle D’Aqui (106XH16/UAE)
Person Responsible: Muhammad Ali Fazal Amin (10103705/PAK (UAE)
Trainer: Ahmed Ali Salman Hassan Al Sabri (10041041/UAE)
Event: CEI2*120 – Bou Thib (UAE), 24-25.12.2021
Prohibited Substance(s): Testosterone
Date of notification: 8 March 2022
Details on these case can be found here.
More at:
https://inside.fei.org/media-updates/fei-tribunal-issues-consent-awards-equine-anti-doping-case-0
No comments:
Post a Comment